Inventor · disambiguated record
Ivo Lorenz
Also filed as: LORENZ IVO · LORENZ IVO C
13 granted patents·24 pending applications·16 citations·filing 2006–2025
87Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER16INT AIDS VACCINE INITIATIVE6UNIV CORNELL4BOEHRINGER INGELHEIM INT3UNIV ROCKEFELLER2
Top patents by PatentIndex Score
37 records- 0189US11242407B2High-affinity anti-MERTK antibodies and uses thereofRGENIX INC·Filed 2020·Granted Feb 8, 2022·4 cites·37 claims
- 0285US9347065B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2013·Granted May 24, 2016·7 cites·4 claims
- 0384US12241097B2Compositions and methods for adoptive cell therapy for cancerMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Mar 4, 2025·2 cites·16 claims
- 0481US11795219B2Antibody molecules for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 24, 2023·1 cites·38 claims
- 0578US12441789B2DLL3-targeting antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Oct 14, 2025·1 cites·17 claims
- 0675US11028169B2Antibody molecules for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jun 8, 2021·1 cites·67 claims
- 0774US10844095B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Nov 24, 2020·0 cites·7 claims
- 0874US2024124581A1Antibody molecules for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0973US11891416B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE INC·Filed 2020·Granted Feb 6, 2024·0 cites·9 claims
- 1066US12281174B2High-affinity anti-MERTK antibodies and uses thereofINSPIRNA INC·Filed 2021·Granted Apr 22, 2025·0 cites·20 claims
- 1165US2024131070A1Antigen recognizing receptors targeting upar and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1265US2024254253A1ANTI-uPAR ANTIBODIES AND USES THEREOFMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1363US10202424B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Feb 12, 2019·0 cites·11 claims
- 1463US9802986B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 31, 2017·0 cites·8 claims
- 1562US2024216557A1Radioligand binding to anti-dll3 antibodies for pretargeted pet imaging and therapeutic uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1662US2025353925A1Coronavirus-inhibiting antibodiesUNIV ROCKEFELLER·Filed 2023·Application pending·0 cites
- 1762US2024368269A1Anti-dll3 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 1861US2025345420A1Cancer immunotherapies to promote hyperacute rejectionUNIV CORNELL·Filed 2023·Application pending·0 cites
- 1960US2024197879A1Antigen recognizing receptors targeting cd33 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2059US2024262910A1Anti-cd33 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2159US2010215691A1Recombinant viral vectorsPARKS CHRISTOPHER L·Filed 2010·Application pending·0 cites
- 2259US2025382381A1Targeting art1 for cancer immunotherapyUNIV CORNELL·Filed 2023·Application pending·0 cites
- 2359US2024109973A1Cd40 binding molecules and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2458US9402894B2Viral particles derived from an enveloped virusINT AIDS VACCINE INITIATIVE·Filed 2012·Granted Aug 2, 2016·0 cites·7 claims
- 2556US2024026009A1Antibodies to galectin-3 and methods of use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2654US2024115721A1Anti-dll3 antibody-drug conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2754US2024115720A1Antibody-pyrrolobenzodiazepine derivative conjugateMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2853US9944935B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Apr 17, 2018·0 cites·11 claims
- 2953US2024392013A1Il1rap antibodies and uses thereofSTELEXIS THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 3053US2024000959A1Cancer immunotherapies to promote hyperacute rejectionUNIV CORNELL·Filed 2021·Application pending·0 cites
- 3153US2022213211A1Antigen recognizing receptors targeting cd371 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3252US2025340636A1Antibodies targeting l1cam and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 3352US2022195064A1Anti-cd371 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 3448US2023391890A1Therapeutic cemip antibodiesUNIV CORNELL·Filed 2021·Application pending·0 cites
- 3544US2023190797A1Compositions and methods for adoptive cell therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
- 3643US2009233266A1Structure of the hepatitis c virus ns2 proteinUNIV ROCKEFELLER·Filed 2006·Application pending·0 cites
- 3742US2022153863A1Prame binding molecules and uses thereofULMERT HANS DAVID STAFFAN·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →